Development of murine leukemia virus-based self-activating vectors that efficiently delete the selectable drug resistance gene during reverse transcription.
about
Utilization of nonviral sequences for minus-strand DNA transfer and gene reconstitution during retroviral replication.Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching.Gene therapy: design and prospects for craniofacial regeneration.Mechanisms and factors that influence high frequency retroviral recombination
P2860
Development of murine leukemia virus-based self-activating vectors that efficiently delete the selectable drug resistance gene during reverse transcription.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Development of murine leukemia ...... during reverse transcription.
@ast
Development of murine leukemia ...... during reverse transcription.
@en
type
label
Development of murine leukemia ...... during reverse transcription.
@ast
Development of murine leukemia ...... during reverse transcription.
@en
prefLabel
Development of murine leukemia ...... during reverse transcription.
@ast
Development of murine leukemia ...... during reverse transcription.
@en
P2860
P1433
P1476
Development of murine leukemia ...... during reverse transcription.
@en
P2093
K A Delviks
V K Pathak
P2860
P304
P577
1999-10-01T00:00:00Z